AirSculpt Technologies (NASDAQ:AIRS) Price Target Cut to $6.00 by Analysts at Piper Sandler

AirSculpt Technologies (NASDAQ:AIRS) had its price objective decreased by Piper Sandler from $7.00 to $6.00 in a research note published on Monday,Benzinga reports. Piper Sandler currently has a neutral rating on the stock.

Separately, BTIG Research started coverage on shares of AirSculpt Technologies in a research report on Thursday, October 17th. They issued a “neutral” rating on the stock. Five equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $5.50.

AirSculpt Technologies Stock Up 2.2 %

NASDAQ:AIRS opened at $5.98 on Monday. The stock has a market cap of $346.13 million, a price-to-earnings ratio of -42.71 and a beta of 1.71. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.80. The stock has a 50-day moving average price of $6.39 and a two-hundred day moving average price of $5.19. AirSculpt Technologies has a 1 year low of $2.92 and a 1 year high of $9.20.

AirSculpt Technologies (NASDAQ:AIRS) last posted its earnings results on Friday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05). AirSculpt Technologies had a positive return on equity of 2.22% and a negative net margin of 4.13%. The business had revenue of $42.55 million for the quarter, compared to the consensus estimate of $42.49 million. During the same period in the previous year, the company posted ($0.01) earnings per share. As a group, equities analysts expect that AirSculpt Technologies will post 0.08 earnings per share for the current year.

Insiders Place Their Bets

In other AirSculpt Technologies news, CEO Dennis Dean sold 24,510 shares of the business’s stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $6.54, for a total transaction of $160,295.40. Following the sale, the chief executive officer now directly owns 582,052 shares of the company’s stock, valued at $3,806,620.08. The trade was a 4.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 78.77% of the company’s stock.

Institutional Trading of AirSculpt Technologies

Several institutional investors and hedge funds have recently bought and sold shares of AIRS. Barclays PLC grew its stake in AirSculpt Technologies by 227.0% in the third quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after purchasing an additional 13,259 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of AirSculpt Technologies by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after buying an additional 21,339 shares during the last quarter. Finally, SW Investment Management LLC grew its stake in shares of AirSculpt Technologies by 5.0% in the second quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock valued at $18,000,000 after buying an additional 213,677 shares in the last quarter. Institutional investors own 91.54% of the company’s stock.

About AirSculpt Technologies

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.